{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T15:01:56Z","timestamp":1790434916243,"version":"4.1.0"},"reference-count":121,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2014,7,8]],"date-time":"2014-07-08T00:00:00Z","timestamp":1404777600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Rev Rheumatol"],"published-print":{"date-parts":[[2014,8]]},"DOI":"10.1038\/nrrheum.2014.98","type":"journal-article","created":{"date-parts":[[2014,7,8]],"date-time":"2014-07-08T09:07:09Z","timestamp":1404810429000},"page":"474-483","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":167,"title":["Eosinophils in vasculitis: characteristics and roles in pathogenesis"],"prefix":"10.1038","volume":"10","author":[{"given":"Paneez","family":"Khoury","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter C.","family":"Grayson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amy D.","family":"Klion","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2014,7,8]]},"reference":[{"key":"BFnrrheum201498_CR1","doi-asserted-by":"publisher","first-page":"1094","DOI":"10.1002\/art.1780330806","volume":"33","author":"AT Masi","year":"1990","unstructured":"Masi, A. T. et al. The American College of Rheumatology 1990 criteria for the classification of Churg\u2013Strauss syndrome (allergic granulomatosis and angiitis). Arthritis Rheum. 33, 1094\u20131100 (1990).","journal-title":"Arthritis Rheum."},{"key":"BFnrrheum201498_CR2","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1002\/art.1780370206","volume":"37","author":"JC Jennette","year":"1994","unstructured":"Jennette, J. C. et al. Nomenclature of systemic vasculitides. Proposal of an international consensus conference. Arthritis Rheum. 37, 187\u2013192 (1994).","journal-title":"Arthritis Rheum."},{"key":"BFnrrheum201498_CR3","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1016\/S0065-2776(08)60351-X","volume":"39","author":"GJ Gleich","year":"1986","unstructured":"Gleich, G. J. & Adolphson, C. R. The eosinophilic leukocyte: structure and function. Adv. Immunol. 39, 177\u2013253 (1986).","journal-title":"Adv. Immunol."},{"key":"BFnrrheum201498_CR4","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1016\/S0046-8177(79)80028-3","volume":"10","author":"FG Mullick","year":"1979","unstructured":"Mullick, F. G., McAllister, H. A. Jr, Wagner, B. M. & Fenoglio, J. J. Jr. Drug related vasculitis. Clinicopathologic correlations in 30 patients. Hum. Pathol. 10, 313\u2013325 (1979).","journal-title":"Hum. Pathol."},{"key":"BFnrrheum201498_CR5","doi-asserted-by":"publisher","first-page":"923","DOI":"10.1016\/0002-9343(82)90853-1","volume":"72","author":"M Robinowitz","year":"1982","unstructured":"Robinowitz, M., Virmani, R. & McAllister, H. A. J. Spontaneous coronary artery dissection and eosinophilic inflammation: a cause and effect relationship? Am. J. Med. 72, 923\u2013928 (1982).","journal-title":"Am. J. Med."},{"key":"BFnrrheum201498_CR6","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1038\/nature12526","volume":"502","author":"JC Nussbaum","year":"2013","unstructured":"Nussbaum, J. C. et al. Type 2 innate lymphoid cells control eosinophil homeostasis. Nature 502, 245\u2013248 (2013).","journal-title":"Nature"},{"key":"BFnrrheum201498_CR7","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1016\/S0002-9440(10)62258-4","volume":"166","author":"AE John","year":"2005","unstructured":"John, A. E., Thomas, M. S., Berlin, A. A. & Lukacs, N. W. Temporal production of CCL28 corresponds to eosinophil accumulation and airway hyperreactivity in allergic airway inflammation. Am. J. Pathol. 166, 345\u2013353 (2005).","journal-title":"Am. J. Pathol."},{"key":"BFnrrheum201498_CR8","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1111\/j.1365-2222.2008.02958.x","volume":"38","author":"SP Hogan","year":"2008","unstructured":"Hogan, S. P. et al. Eosinophils: biological properties and role in health and disease. Clin. Exp. Allergy 38, 709\u2013750 (2008).","journal-title":"Clin. Exp. Allergy"},{"key":"BFnrrheum201498_CR9","doi-asserted-by":"publisher","first-page":"1667","DOI":"10.1111\/j.1365-2222.2000.00991.x","volume":"30","author":"R Moqbel","year":"2000","unstructured":"Moqbel, R. & Lacy, P. New concepts in effector functions of eosinophil cytokines. Clin. Exp. Allergy 30, 1667\u20131671 (2000).","journal-title":"Clin. Exp. Allergy"},{"key":"BFnrrheum201498_CR10","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1097\/00062752-200101000-00006","volume":"8","author":"GM Walsh","year":"2001","unstructured":"Walsh, G. M. Eosinophil granule proteins and their role in disease. Curr. Opin. Hematol. 8, 28\u201333 (2001).","journal-title":"Curr. Opin. Hematol."},{"key":"BFnrrheum201498_CR11","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1182\/blood.V72.1.150.150","volume":"72","author":"AM Dvorak","year":"1988","unstructured":"Dvorak, A. M., Letourneau, L., Login, G. R., Weller, P. F. & Ackerman, S. J. Ultrastructural localization of the Charcot\u2013Leyden crystal protein (lysophospholipase) to a distinct crystalloid-free granule population in mature human eosinophils. Blood 72, 150\u2013158 (1988).","journal-title":"Blood"},{"key":"BFnrrheum201498_CR12","doi-asserted-by":"publisher","first-page":"e59578","DOI":"10.1371\/journal.pone.0059578","volume":"8","author":"RC Melo","year":"2013","unstructured":"Melo, R. C., Paganoti, G. F., Dvorak, A. M. & Weller, P. F. The internal architecture of leukocyte lipid body organelles captured by three-dimensional electron microscopy tomography. PLoS ONE 8, e59578 (2013).","journal-title":"PLoS ONE"},{"key":"BFnrrheum201498_CR13","doi-asserted-by":"publisher","first-page":"769","DOI":"10.1038\/labinvest.2009.40","volume":"89","author":"RC Melo","year":"2009","unstructured":"Melo, R. C. et al. Vesicle-mediated secretion of human eosinophil granule-derived major basic protein. Lab. Invest. 89, 769\u2013781 (2009).","journal-title":"Lab. Invest."},{"key":"BFnrrheum201498_CR14","doi-asserted-by":"publisher","first-page":"866","DOI":"10.1111\/j.1600-0854.2005.00322.x","volume":"6","author":"RC Melo","year":"2005","unstructured":"Melo, R. C., Perez, S. A., Spencer, L. A., Dvorak, A. M. & Weller, P. F. Intragranular vesiculotubular compartments are involved in piecemeal degranulation by activated human eosinophils. Traffic 6, 866\u2013879 (2005).","journal-title":"Traffic"},{"key":"BFnrrheum201498_CR15","doi-asserted-by":"publisher","first-page":"3333","DOI":"10.1073\/pnas.0508946103","volume":"103","author":"LA Spencer","year":"2006","unstructured":"Spencer, L. A. et al. Cytokine receptor-mediated trafficking of preformed IL-4 in eosinophils identifies an innate immune mechanism of cytokine secretion. Proc. Natl Acad. Sci. USA 103, 3333\u20133338 (2006).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"BFnrrheum201498_CR16","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1189\/jlb.0108058","volume":"85","author":"LA Spencer","year":"2009","unstructured":"Spencer, L. A. et al. Human eosinophils constitutively express multiple TH1, TH2, and immunoregulatory cytokines that are secreted rapidly and differentially. J. Leukoc. Biol. 85, 117\u2013123 (2009).","journal-title":"J. Leukoc. Biol."},{"key":"BFnrrheum201498_CR17","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1016\/j.jaci.2009.11.029","volume":"125","author":"JS Neves","year":"2010","unstructured":"Neves, J. S., Radke, A. L. & Weller, P. F. Cysteinyl leukotrienes acting via granule membrane-expressed receptors elicit secretion from within cell-free human eosinophil granules. J. Allergy Clin. Immunol. 125, 477\u2013482 (2010).","journal-title":"J. Allergy Clin. Immunol."},{"key":"BFnrrheum201498_CR18","doi-asserted-by":"publisher","first-page":"18478","DOI":"10.1073\/pnas.0804547105","volume":"105","author":"JS Neves","year":"2008","unstructured":"Neves, J. S. et al. Eosinophil granules function extracellularly as receptor-mediated secretory organelles. Proc. Natl Acad. Sci. USA 105, 18478\u201318483 (2008).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"BFnrrheum201498_CR19","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1056\/NEJMc1103005","volume":"365","author":"BL Wright","year":"2011","unstructured":"Wright, B. L., Leiferman, K. M. & Gleich, G. J. Eosinophil granule protein localization in eosinophilic endomyocardial disease. N. Engl. J. Med. 365, 187\u2013188 (2011).","journal-title":"N. Engl. J. Med."},{"key":"BFnrrheum201498_CR20","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1067\/mjd.2002.124600","volume":"47","author":"LA Drage","year":"2002","unstructured":"Drage, L. A. et al. Evidence for pathogenic involvement of eosinophils and neutrophils in Churg\u2013Strauss syndrome. J. Am. Acad. Dermatol. 47, 209\u2013216 (2002).","journal-title":"J. Am. Acad. Dermatol."},{"key":"BFnrrheum201498_CR21","doi-asserted-by":"publisher","unstructured":"Saffari, H. et al. Electron microscopy elucidates eosinophil degranulation patterns in patients with eosinophilic esophagitis. J. Allergy Clin. Immunol. http:\/\/dx.doi.org\/10.1016\/j.jaci.2013.11.024 (2014).","DOI":"10.1016\/j.jaci.2013.11.024"},{"key":"BFnrrheum201498_CR22","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1016\/S0065-2776(08)01003-1","volume":"101","author":"C Blanchard","year":"2009","unstructured":"Blanchard, C. & Rothenberg, M. E. Biology of the eosinophil. Adv. Immunol. 101, 81\u2013121 (2009).","journal-title":"Adv. Immunol."},{"key":"BFnrrheum201498_CR23","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1038\/nri3341","volume":"13","author":"HF Rosenberg","year":"2013","unstructured":"Rosenberg, H. F., Dyer, K. D. & Foster, P. S. Eosinophils: changing perspectives in health and disease. Nat. Rev. Immunol. 13, 9\u201322 (2013).","journal-title":"Nat. Rev. Immunol."},{"key":"BFnrrheum201498_CR24","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1111\/j.1365-2222.2010.03484.x","volume":"40","author":"JJ Lee","year":"2010","unstructured":"Lee, J. J., Jacobsen, E. A., McGarry, M. P., Schleimer, R. P. & Lee, N. A. Eosinophils in health and disease: the LIAR hypothesis. Clin. Exp. Allergy 40, 563\u2013575 (2010).","journal-title":"Clin. Exp. Allergy"},{"key":"BFnrrheum201498_CR25","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1038\/ni.1981","volume":"12","author":"VT Chu","year":"2011","unstructured":"Chu, V. T. et al. Eosinophils are required for the maintenance of plasma cells in the bone marrow. Nat. Immunol. 12, 151\u2013159 (2011).","journal-title":"Nat. Immunol."},{"key":"BFnrrheum201498_CR26","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1126\/science.1201475","volume":"332","author":"D Wu","year":"2011","unstructured":"Wu, D. et al. Eosinophils sustain adipose alternatively activated macrophages associated with glucose homeostasis. Science 332, 243\u2013247 (2011).","journal-title":"Science"},{"key":"BFnrrheum201498_CR27","first-page":"521","volume":"140","author":"H Noguchi","year":"1992","unstructured":"Noguchi, H., Kephart, G. M., Colby, T. V. & Gleich, G. J. Tissue eosinophilia and eosinophil degranulation in syndromes associated with fibrosis. Am. J. Pathol. 140, 521\u2013528 (1992).","journal-title":"Am. J. Pathol."},{"key":"BFnrrheum201498_CR28","doi-asserted-by":"publisher","first-page":"1470","DOI":"10.1172\/JCI115155","volume":"87","author":"RH Gundel","year":"1991","unstructured":"Gundel, R. H., Letts, L. G. & Gleich, G. J. Human eosinophil major basic protein induces airway constriction and airway hyperresponsiveness in primates. J. Clin. Invest. 87, 1470\u20131473 (1991).","journal-title":"J. Clin. Invest."},{"key":"BFnrrheum201498_CR29","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1016\/S0024-3205(98)00587-6","volume":"64","author":"AD Fryer","year":"1999","unstructured":"Fryer, A. D., Adamko, D. J., Yost, B. L. & Jacoby, D. B. Effects of inflammatory cells on neuronal M2 muscarinic receptor function in the lung. Life Sci. 64, 449\u2013455 (1999).","journal-title":"Life Sci."},{"key":"BFnrrheum201498_CR30","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1016\/0091-6749(91)90159-L","volume":"88","author":"J Bousquet","year":"1991","unstructured":"Bousquet, J. et al. Indirect evidence of bronchial inflammation assessed by titration of inflammatory mediators in BAL fluid of patients with asthma. J. Allergy Clin. Immunol. 88, 649\u2013660 (1991).","journal-title":"J. Allergy Clin. Immunol."},{"key":"BFnrrheum201498_CR31","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/S0140-6736(82)91152-7","volume":"2","author":"WV Filley","year":"1982","unstructured":"Filley, W. V., Holley, K. E., Kephart, G. M. & Gleich, G. J. Identification by immunofluorescence of eosinophil granule major basic protein in lung tissues of patients with bronchial asthma. Lancet 2, 11\u201316 (1982).","journal-title":"Lancet"},{"key":"BFnrrheum201498_CR32","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1038\/ajg.2009.584","volume":"105","author":"GM Kephart","year":"2010","unstructured":"Kephart, G. M. et al. Marked deposition of eosinophil-derived neurotoxin in adult patients with eosinophilic esophagitis. Am. J. Gastroenterol. 105, 298\u2013307 (2010).","journal-title":"Am. J. Gastroenterol."},{"key":"BFnrrheum201498_CR33","doi-asserted-by":"publisher","first-page":"9660","DOI":"10.1073\/pnas.96.17.9660","volume":"96","author":"F Levi-Schaffer","year":"1999","unstructured":"Levi-Schaffer, F. et al. Human eosinophils regulate human lung- and skin-derived fibroblast properties in vitro: a role for transforming growth factor beta (TGF-\u03b2). Proc. Natl Acad. Sci. USA 96, 9660\u20139665 (1999).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"BFnrrheum201498_CR34","doi-asserted-by":"publisher","first-page":"1776","DOI":"10.1126\/science.1100283","volume":"305","author":"AA Humbles","year":"2004","unstructured":"Humbles, A. A. et al. A critical role for eosinophils in allergic airways remodeling. Science 305, 1776\u20131779 (2004).","journal-title":"Science"},{"key":"BFnrrheum201498_CR35","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1111\/j.1365-2249.2004.02396.x","volume":"135","author":"U Zagai","year":"2004","unstructured":"Zagai, U., Skold, C. M., Trulson, A., Venge, P. & Lundahl, J. The effect of eosinophils on collagen gel contraction and implications for tissue remodelling. Clin. Exp. Immunol. 135, 427\u2013433 (2004).","journal-title":"Clin. Exp. Immunol."},{"key":"BFnrrheum201498_CR36","doi-asserted-by":"publisher","first-page":"796","DOI":"10.1016\/j.jaci.2005.06.031","volume":"116","author":"I Gomes","year":"2005","unstructured":"Gomes, I. et al. Eosinophil-fibroblast interactions induce fibroblast IL-6 secretion and extracellular matrix gene expression: implications in fibrogenesis. J. Allergy Clin. Immunol. 116, 796\u2013804 (2005).","journal-title":"J. Allergy Clin. Immunol."},{"key":"BFnrrheum201498_CR37","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1007\/s10753-007-9032-4","volume":"30","author":"U Zagai","year":"2007","unstructured":"Zagai, U., Dadfar, E., Lundahl, J., Venge, P. & Skold, C. M. Eosinophil cationic protein stimulates TGF-\u03b21 release by human lung fibroblasts in vitro. Inflammation 30, 153\u2013160 (2007).","journal-title":"Inflammation"},{"key":"BFnrrheum201498_CR38","doi-asserted-by":"publisher","first-page":"628","DOI":"10.1177\/1076029609348647","volume":"16","author":"PR Ames","year":"2010","unstructured":"Ames, P. R., Margaglione, M., Mackie, S. & Alves, J. D. Eosinophilia and thrombophilia in Churg\u2013Strauss syndrome: a clinical and pathogenetic overview. Clin. Appl. Thromb. Hemost. 16, 628\u2013636 (2010).","journal-title":"Clin. Appl. Thromb. Hemost."},{"key":"BFnrrheum201498_CR39","doi-asserted-by":"publisher","first-page":"995","DOI":"10.1182\/blood-2006-02-004945","volume":"109","author":"C Moosbauer","year":"2007","unstructured":"Moosbauer, C. et al. Eosinophils are a major intravascular location for tissue factor storage and exposure. Blood 109, 995\u20131002 (2007).","journal-title":"Blood"},{"key":"BFnrrheum201498_CR40","doi-asserted-by":"publisher","first-page":"892","DOI":"10.1111\/j.1365-2141.1995.tb05211.x","volume":"90","author":"HY Mukai","year":"1995","unstructured":"Mukai, H. Y., Ninomiya, H., Ohtani, K., Nagasawa, T. & Abe, T. Major basic protein binding to thrombomodulin potentially contributes to the thrombosis in patients with eosinophilia. Br. J. Haematol. 90, 892\u2013899 (1995).","journal-title":"Br. J. Haematol."},{"key":"BFnrrheum201498_CR41","doi-asserted-by":"publisher","first-page":"1721","DOI":"10.1172\/JCI116382","volume":"91","author":"A Slungaard","year":"1993","unstructured":"Slungaard, A., Vercellotti, G. M., Tran, T., Gleich, G. J. & Key, N. S. Eosinophil cationic granule proteins impair thrombomodulin function. A potential mechanism for thromboembolism in hypereosinophilic heart disease. J. Clin. Invest. 91, 1721\u20131730 (1993).","journal-title":"J. Clin. Invest."},{"key":"BFnrrheum201498_CR42","doi-asserted-by":"publisher","first-page":"1271","DOI":"10.1084\/jem.172.4.1271","volume":"172","author":"MS Rohrbach","year":"1990","unstructured":"Rohrbach, M. S., Wheatley, C. L., Slifman, N. R. & Gleich, G. J. Activation of platelets by eosinophil granule proteins. J. Exp. Med. 172, 1271\u20131274 (1990).","journal-title":"J. Exp. Med."},{"key":"BFnrrheum201498_CR43","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1002\/mus.880060408","volume":"6","author":"LJ Dorfman","year":"1983","unstructured":"Dorfman, L. J., Ransom, B. R., Forno, L. S. & Kelts, A. Neuropathy in the hypereosinophilic syndrome. Muscle Nerve 6, 291\u2013298 (1983).","journal-title":"Muscle Nerve"},{"key":"BFnrrheum201498_CR44","doi-asserted-by":"publisher","first-page":"1140","DOI":"10.1212\/WNL.35.8.1140","volume":"35","author":"A Wichman","year":"1985","unstructured":"Wichman, A., Buchthal, F., Pezeshkpour, G. H. & Fauci, A. S. Peripheral neuropathy in hypereosinophilic syndrome. Neurology 35, 1140\u20131145 (1985).","journal-title":"Neurology"},{"key":"BFnrrheum201498_CR45","doi-asserted-by":"publisher","first-page":"450","DOI":"10.1590\/S0004-282X1991000400015","volume":"49","author":"O Nascimento","year":"1991","unstructured":"Nascimento, O., De Freitas, M., Chimelli, L. & Scaravilli, F. Peripheral neuropathy in hypereosinophilic syndrome with vasculitis. Arq. Neuropsiquiatr. 49, 450\u2013455 (1991).","journal-title":"Arq. Neuropsiquiatr."},{"key":"BFnrrheum201498_CR46","first-page":"L93","volume":"273","author":"RW Costello","year":"1997","unstructured":"Costello, R. W. et al. Localization of eosinophils to airway nerves and effect on neuronal M2 muscarinic receptor function. Am. J. Physiol. 273, L93\u2013L103 (1997).","journal-title":"Am. J. Physiol."},{"key":"BFnrrheum201498_CR47","doi-asserted-by":"publisher","first-page":"L915","DOI":"10.1152\/ajplung.00094.2003","volume":"285","author":"PJ Kingham","year":"2003","unstructured":"Kingham, P. J. et al. Effects of eosinophils on nerve cell morphology and development: the role of reactive oxygen species and p38 MAP kinase. Am. J. Physiol. Lung Cell. Mol. Physiol. 285, L915\u2013L924 (2003).","journal-title":"Am. J. Physiol. Lung Cell. Mol. Physiol."},{"key":"BFnrrheum201498_CR48","first-page":"277","volume":"27","author":"J Churg","year":"1951","unstructured":"Churg, J. & Strauss, L. Allergic granulomatosis, allergic angiitis, and periarteritis nodosa. Am. J. Pathol. 27, 277\u2013301 (1951).","journal-title":"Am. J. Pathol."},{"key":"BFnrrheum201498_CR49","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1002\/art.37715","volume":"65","author":"JC Jennette","year":"2013","unstructured":"Jennette, J. C. et al. 2012 revised International Chapel Hill Consensus Conference Nomenclature of Vasculitides. Arthritis Rheum. 65, 1\u201311 (2013).","journal-title":"Arthritis Rheum."},{"key":"BFnrrheum201498_CR50","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1097\/00005792-198403000-00001","volume":"63","author":"JG Lanham","year":"1984","unstructured":"Lanham, J. G., Elkon, K. B., Pusey, C. D. & Hughes, G. R. Systemic vasculitis with asthma and eosinophilia: a clinical approach to the Churg\u2013Strauss syndrome. Medicine (Baltimore) 63, 65\u201381 (1984).","journal-title":"Medicine (Baltimore)"},{"key":"BFnrrheum201498_CR51","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1002\/art.37721","volume":"65","author":"C Comarmond","year":"2013","unstructured":"Comarmond, C. et al. Eosinophilic granulomatosis with polyangiitis (Churg\u2013Strauss): clinical characteristics and long-term followup of the 383 patients enrolled in the French Vasculitis Study Group cohort. Arthritis Rheum. 65, 270\u2013281 (2013).","journal-title":"Arthritis Rheum."},{"key":"BFnrrheum201498_CR52","doi-asserted-by":"publisher","first-page":"1905","DOI":"10.3899\/jrheum.121473","volume":"40","author":"PC Grayson","year":"2013","unstructured":"Grayson, P. C. et al. New features of disease after diagnosis in 6 forms of systemic vasculitis. J. Rheumatol. 40, 1905\u20131912 (2013).","journal-title":"J. Rheumatol."},{"key":"BFnrrheum201498_CR53","doi-asserted-by":"publisher","first-page":"632","DOI":"10.7326\/0003-4819-143-9-200511010-00006","volume":"143","author":"R Sable-Fourtassou","year":"2005","unstructured":"Sable-Fourtassou, R. et al. Antineutrophil cytoplasmic antibodies and the Churg\u2013Strauss syndrome. Ann. Intern. Med. 143, 632\u2013638 (2005).","journal-title":"Ann. Intern. Med."},{"key":"BFnrrheum201498_CR54","doi-asserted-by":"publisher","first-page":"2926","DOI":"10.1002\/art.21250","volume":"52","author":"RA Sinico","year":"2005","unstructured":"Sinico, R. A. et al. Prevalence and clinical significance of antineutrophil cytoplasmic antibodies in Churg\u2013Strauss syndrome. Arthritis Rheum. 52, 2926\u20132935 (2005).","journal-title":"Arthritis Rheum."},{"key":"BFnrrheum201498_CR55","doi-asserted-by":"publisher","first-page":"1440","DOI":"10.1016\/j.jaci.2012.09.031","volume":"130","author":"RA Sinico","year":"2012","unstructured":"Sinico, R. A., Bottero, P. & Guillevin, L. Antineutrophil cytoplasmic autoantibodies and clinical phenotype in patients with Churg\u2013Strauss syndrome. J. Allergy Clin. Immunol. 130, 1440 (2012).","journal-title":"J. Allergy Clin. Immunol."},{"key":"BFnrrheum201498_CR56","doi-asserted-by":"publisher","first-page":"1011","DOI":"10.1136\/annrheumdis-2012-201531","volume":"72","author":"F Moosig","year":"2013","unstructured":"Moosig, F. et al. A vasculitis centre based management strategy leads to improved outcome in eosinophilic granulomatosis and polyangiitis (Churg\u2013Strauss, EGPA): monocentric experiences in 150 patients. Ann. Rheum. Dis. 72, 1011\u20131017 (2013).","journal-title":"Ann. Rheum. Dis."},{"key":"BFnrrheum201498_CR57","doi-asserted-by":"publisher","first-page":"1149","DOI":"10.1111\/j.1398-9995.2012.02873.x","volume":"67","author":"P Khoury","year":"2012","unstructured":"Khoury, P. et al. Serum biomarkers are similar in Churg\u2013Strauss syndrome and hypereosinophilic syndrome. Allergy 67, 1149\u20131156 (2012).","journal-title":"Allergy"},{"key":"BFnrrheum201498_CR58","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1586\/ehm.11.81","volume":"5","author":"P Valent","year":"2012","unstructured":"Valent, P. et al. Pathogenesis and classification of eosinophil disorders: a review of recent developments in the field. Expert Rev. Hematol. 5, 157\u2013176 (2012).","journal-title":"Expert Rev. Hematol."},{"key":"BFnrrheum201498_CR59","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1097\/BOR.0000000000000015","volume":"26","author":"A Mahr","year":"2014","unstructured":"Mahr, A. et al. Eosinophilic granulomatosis with polyangiitis (Churg\u2013Strauss): evolutions in classification, etiopathogenesis, assessment and management. Curr. Opin. Rheumatol. 26, 16\u201323 (2014).","journal-title":"Curr. Opin. Rheumatol."},{"key":"BFnrrheum201498_CR60","doi-asserted-by":"publisher","first-page":"3159","DOI":"10.1002\/art.22834","volume":"56","author":"A Vaglio","year":"2007","unstructured":"Vaglio, A. et al. HLA-DRB4 as a genetic risk factor for Churg\u2013Strauss syndrome. Arthritis Rheum. 56, 3159\u20133166 (2007).","journal-title":"Arthritis Rheum."},{"key":"BFnrrheum201498_CR61","doi-asserted-by":"publisher","first-page":"716","DOI":"10.1038\/nm.2678","volume":"18","author":"SE Wenzel","year":"2012","unstructured":"Wenzel, S. E. Asthma phenotypes: the evolution from clinical to molecular approaches. Nat. Med. 18, 716\u2013725 (2012).","journal-title":"Nat. Med."},{"key":"BFnrrheum201498_CR62","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1016\/j.jaci.2003.10.041","volume":"113","author":"C Miranda","year":"2004","unstructured":"Miranda, C., Busacker, A., Balzar, S., Trudeau, J. & Wenzel, S. E. Distinguishing severe asthma phenotypes: role of age at onset and eosinophilic inflammation. J. Allergy Clin. Immunol. 113, 101\u2013108 (2004).","journal-title":"J. Allergy Clin. Immunol."},{"key":"BFnrrheum201498_CR63","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.1111\/all.12206","volume":"68","author":"P Nair","year":"2013","unstructured":"Nair, P. et al. Eosinophil peroxidase in sputum represents a unique biomarker of airway eosinophilia. Allergy 68, 1177\u20131184 (2013).","journal-title":"Allergy"},{"key":"BFnrrheum201498_CR64","doi-asserted-by":"publisher","first-page":"1074","DOI":"10.1002\/art.1780330804","volume":"33","author":"JT Lie","year":"1990","unstructured":"Lie, J. T. Illustrated histopathologic classification criteria for selected vasculitis syndromes. American College of Rheumatology Subcommittee on Classification of Vasculitis. Arthritis Rheum. 33, 1074\u20131087 (1990).","journal-title":"Arthritis Rheum."},{"key":"BFnrrheum201498_CR65","doi-asserted-by":"publisher","first-page":"767","DOI":"10.1309\/F3FW-J8EB-X913-G1RJ","volume":"114","author":"AL Katzenstein","year":"2000","unstructured":"Katzenstein, A. L. Diagnostic features and differential diagnosis of Churg\u2013Strauss syndrome in the lung. A review. Am. J. Clin. Pathol. 114, 767\u2013772 (2000).","journal-title":"Am. J. Clin. Pathol."},{"key":"BFnrrheum201498_CR66","doi-asserted-by":"publisher","first-page":"1284","DOI":"10.1038\/modpathol.3880475","volume":"14","author":"A Churg","year":"2001","unstructured":"Churg, A. Recent advances in the diagnosis of Churg\u2013Strauss syndrome. Mod. Pathol. 14, 1284\u20131293 (2001).","journal-title":"Mod. Pathol."},{"key":"BFnrrheum201498_CR67","doi-asserted-by":"publisher","first-page":"955","DOI":"10.1172\/JCI0215918","volume":"110","author":"H Xiao","year":"2002","unstructured":"Xiao, H. et al. Antineutrophil cytoplasmic autoantibodies specific for myeloperoxidase cause glomerulonephritis and vasculitis in mice. J. Clin. Invest. 110, 955\u2013963 (2002).","journal-title":"J. Clin. Invest."},{"key":"BFnrrheum201498_CR68","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1097\/BOR.0b013e32834d2d52","volume":"24","author":"AD Salama","year":"2012","unstructured":"Salama, A. D. & Little, M. A. Animal models of antineutrophil cytoplasm antibody-associated vasculitis. Curr. Opin. Rheumatol. 24, 1\u20137 (2012).","journal-title":"Curr. Opin. Rheumatol."},{"key":"BFnrrheum201498_CR69","doi-asserted-by":"publisher","first-page":"2225","DOI":"10.2353\/ajpath.2009.080223","volume":"174","author":"T Ishii","year":"2009","unstructured":"Ishii, T. et al. Establishment of experimental eosinophilic vasculitis by IgE-mediated cutaneous reverse passive Arthus reaction. Am. J. Pathol. 174, 2225\u20132233 (2009).","journal-title":"Am. J. Pathol."},{"key":"BFnrrheum201498_CR70","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1002\/1529-0131(200102)44:2<469::AID-ANR66>3.0.CO;2-0","volume":"44","author":"M Kiene","year":"2001","unstructured":"Kiene, M. et al. Elevated interleukin-4 and interleukin-13 production by T cell lines from patients with Churg\u2013Strauss syndrome. Arthritis Rheum. 44, 469\u2013473 (2001).","journal-title":"Arthritis Rheum."},{"key":"BFnrrheum201498_CR71","doi-asserted-by":"publisher","first-page":"1887","DOI":"10.1093\/rheumatology\/kes171","volume":"51","author":"B Jakiela","year":"2012","unstructured":"Jakiela, B. et al. Increased production of IL-5 and dominant TH2-type response in airways of Churg\u2013Strauss syndrome patients. Rheumatology (Oxford) 51, 1887\u20131893 (2012).","journal-title":"Rheumatology (Oxford)"},{"key":"BFnrrheum201498_CR72","doi-asserted-by":"publisher","first-page":"915","DOI":"10.1016\/S0002-9440(10)65191-7","volume":"155","author":"M Muschen","year":"1999","unstructured":"Muschen, M. et al. Involvement of soluble CD95 in Churg\u2013Strauss syndrome. Am. J. Pathol. 155, 915\u2013925 (1999).","journal-title":"Am. J. Pathol."},{"key":"BFnrrheum201498_CR73","doi-asserted-by":"publisher","first-page":"4523","DOI":"10.1182\/blood-2010-02-267542","volume":"116","author":"B Terrier","year":"2010","unstructured":"Terrier, B. et al. Interleukin-25: a cytokine linking eosinophils and adaptive immunity in Churg\u2013Strauss syndrome. Blood 116, 4523\u20134531 (2010).","journal-title":"Blood"},{"key":"BFnrrheum201498_CR74","doi-asserted-by":"publisher","first-page":"977","DOI":"10.1038\/nm.3300","volume":"19","author":"GG Brusselle","year":"2013","unstructured":"Brusselle, G. G., Maes, T. & Bracke, K. R. Eosinophils in the spotlight: eosinophilic airway inflammation in nonallergic asthma. Nat. Med. 19, 977\u2013979 (2013).","journal-title":"Nat. Med."},{"issue":"Suppl. 64","key":"BFnrrheum201498_CR75","first-page":"S23","volume":"29","author":"B Jakiela","year":"2011","unstructured":"Jakiela, B. et al. Both TH2 and TH17 responses are involved in the pathogenesis of Churg\u2013Strauss syndrome. Clin. Exp. Rheumatol. 29 (Suppl. 64), S23\u2013S34 (2011).","journal-title":"Clin. Exp. Rheumatol."},{"issue":"Suppl. 1","key":"BFnrrheum201498_CR76","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1159\/000126065","volume":"146","author":"H Saito","year":"2008","unstructured":"Saito, H., Tsurikisawa, N., Tsuburai, T. & Akiyama, K. Involvement of regulatory T cells in the pathogenesis of Churg\u2013Strauss syndrome. Int. Arch. Allergy Immunol. 146 (Suppl. 1), 73\u201376 (2008).","journal-title":"Int. Arch. Allergy Immunol."},{"key":"BFnrrheum201498_CR77","doi-asserted-by":"publisher","first-page":"965","DOI":"10.1007\/s10875-013-9898-x","volume":"33","author":"N Tsurikisawa","year":"2013","unstructured":"Tsurikisawa, N., Saito, H., Oshikata, C., Tsuburai, T. & Akiyama, K. Decreases in the numbers of peripheral blood regulatory T cells, and increases in the levels of memory and activated B cells, in patients with active eosinophilic granulomatosis and polyangiitis. J. Clin. Immunol. 33, 965\u2013976 (2013).","journal-title":"J. Clin. Immunol."},{"key":"BFnrrheum201498_CR78","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1111\/j.1365-3083.1985.tb01443.x","volume":"21","author":"BJ Manger","year":"1985","unstructured":"Manger, B. J. et al. IgE-containing circulating immune complexes in Churg\u2013Strauss vasculitis. Scand. J. Immunol. 21, 369\u2013373 (1985).","journal-title":"Scand. J. Immunol."},{"key":"BFnrrheum201498_CR79","doi-asserted-by":"publisher","first-page":"1104","DOI":"10.1093\/rheumatology\/ken175","volume":"47","author":"RJ Pepper","year":"2008","unstructured":"Pepper, R. J. et al. Rituximab is effective in the treatment of refractory Churg\u2013Strauss syndrome and is associated with diminished T-cell interleukin-5 production. Rheumatology (Oxford) 47, 1104\u20131105 (2008).","journal-title":"Rheumatology (Oxford)"},{"key":"BFnrrheum201498_CR80","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1093\/rheumatology\/ker280","volume":"51","author":"G Tomasson","year":"2012","unstructured":"Tomasson, G., Grayson, P. C., Mahr, A. D., Lavalley, M. & Merkel, P. A. Value of ANCA measurements during remission to predict a relapse of ANCA-associated vasculitis\u2014a meta-analysis. Rheumatology (Oxford) 51, 100\u2013109 (2012).","journal-title":"Rheumatology (Oxford)"},{"key":"BFnrrheum201498_CR81","doi-asserted-by":"publisher","first-page":"390","DOI":"10.1136\/ard.2011.155382","volume":"71","author":"A Vaglio","year":"2012","unstructured":"Vaglio, A. et al. IgG4 immune response in Churg\u2013Strauss syndrome. Ann. Rheum. Dis. 71, 390\u2013393 (2012).","journal-title":"Ann. Rheum. Dis."},{"issue":"Suppl. 10","key":"BFnrrheum201498_CR82","first-page":"S319","volume":"65","author":"PC Grayson","year":"2013","unstructured":"Grayson, P. C. et al. Clinical value of commonly-measured laboratory tests in eosinophilic granulomatosis with polyangiitis (Churg\u2013Strauss) [abstract #756]. Arthritis Rheum. 65 (Suppl. 10) S319 (2013).","journal-title":"Arthritis Rheum."},{"key":"BFnrrheum201498_CR83","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1097\/BOR.0000000000000009","volume":"26","author":"PA Monach","year":"2014","unstructured":"Monach, P. A. Biomarkers in vasculitis. Curr. Opin. Rheumatol. 26, 24\u201330 (2014).","journal-title":"Curr. Opin. Rheumatol."},{"key":"BFnrrheum201498_CR84","doi-asserted-by":"publisher","first-page":"799","DOI":"10.1053\/rmed.2001.1163","volume":"95","author":"H Meziane","year":"2001","unstructured":"Meziane, H., Maakel, M. L., Vachier, I., Bousquet, J. & Chanez, P. Sputum eosinophilia in Churg\u2013Strauss syndrome. Respir. Med. 95, 799\u2013801 (2001).","journal-title":"Respir. Med."},{"key":"BFnrrheum201498_CR85","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1111\/cea.12236","volume":"44","author":"S Cianchetti","year":"2013","unstructured":"Cianchetti, S. et al. Are sputum ECP and eosinophils differently associated with clinical and functional findings of asthma? Clin. Exp. Allergy 44, 673\u2013680 (2013).","journal-title":"Clin. Exp. Allergy"},{"key":"BFnrrheum201498_CR86","doi-asserted-by":"publisher","first-page":"392","DOI":"10.1196\/annals.1381.041","volume":"1107","author":"P Guilpain","year":"2007","unstructured":"Guilpain, P. et al. Serum eosinophil cationic protein: a marker of disease activity in Churg\u2013Strauss syndrome. Ann. N. Y. Acad. Sci. 1107, 392\u2013399 (2007).","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"BFnrrheum201498_CR87","doi-asserted-by":"publisher","first-page":"804","DOI":"10.1093\/rheumatology\/ken033","volume":"47","author":"K Polzer","year":"2008","unstructured":"Polzer, K. et al. Eotaxin-3 is involved in Churg\u2013Strauss syndrome\u2014a serum marker closely correlating with disease activity. Rheumatology (Oxford) 47, 804\u2013808 (2008).","journal-title":"Rheumatology (Oxford)"},{"key":"BFnrrheum201498_CR88","doi-asserted-by":"publisher","first-page":"1823","DOI":"10.1093\/rheumatology\/keq445","volume":"50","author":"J Zwerina","year":"2011","unstructured":"Zwerina, J. et al. Eotaxin-3 in Churg\u2013Strauss syndrome: a clinical and immunogenetic study. Rheumatology (Oxford) 50, 1823\u20131827 (2011).","journal-title":"Rheumatology (Oxford)"},{"key":"BFnrrheum201498_CR89","doi-asserted-by":"publisher","first-page":"3496","DOI":"10.1002\/art.27678","volume":"62","author":"T Dallos","year":"2010","unstructured":"Dallos, T. et al. CCL17\/thymus and activation-related chemokine in Churg\u2013Strauss syndrome. Arthritis Rheum. 62, 3496\u20133503 (2010).","journal-title":"Arthritis Rheum."},{"key":"BFnrrheum201498_CR90","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1002\/1529-0131(199803)41:3<445::AID-ART10>3.0.CO;2-3","volume":"41","author":"WH Schmitt","year":"1998","unstructured":"Schmitt, W. H. et al. Churg\u2013Strauss syndrome: serum markers of lymphocyte activation and endothelial damage. Arthritis Rheum. 41, 445\u2013452 (1998).","journal-title":"Arthritis Rheum."},{"key":"BFnrrheum201498_CR91","doi-asserted-by":"publisher","first-page":"677","DOI":"10.1136\/thx.2007.087825","volume":"63","author":"T Hauser","year":"2008","unstructured":"Hauser, T. et al. The leucotriene receptor antagonist montelukast and the risk of Churg\u2013Strauss syndrome: a case-crossover study. Thorax 63, 677\u2013682 (2008).","journal-title":"Thorax"},{"key":"BFnrrheum201498_CR92","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1016\/j.jaci.2003.10.068","volume":"113","author":"N Higashi","year":"2004","unstructured":"Higashi, N. et al. Clinical features of asthmatic patients with increased urinary leukotriene E4 excretion (hyperleukotrienuria): involvement of chronic hyperplastic rhinosinusitis with nasal polyposis. J. Allergy Clin. Immunol. 113, 277\u2013283 (2004).","journal-title":"J. Allergy Clin. Immunol."},{"key":"BFnrrheum201498_CR93","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1111\/j.1365-2222.2011.03943.x","volume":"42","author":"W Szczeklik","year":"2012","unstructured":"Szczeklik, W. et al. 12-hydroxy-eicosatetraenoic acid (12-HETE): a biomarker of Churg\u2013Strauss syndrome. Clin. Exp. Allergy 42, 513\u2013522 (2012).","journal-title":"Clin. Exp. Allergy"},{"key":"BFnrrheum201498_CR94","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1136\/ard.2008.088096","volume":"68","author":"C Mukhtyar","year":"2009","unstructured":"Mukhtyar, C. et al. EULAR recommendations for the management of primary small and medium vessel vasculitis. Ann. Rheum. Dis. 68, 310\u2013317 (2009).","journal-title":"Ann. Rheum. Dis."},{"key":"BFnrrheum201498_CR95","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1056\/NEJMoa020286","volume":"349","author":"D Jayne","year":"2003","unstructured":"Jayne, D. et al. A randomized trial of maintenance therapy for vasculitis associated with antineutrophil cytoplasmic autoantibodies. N. Engl. J. Med. 349, 36\u201344 (2003).","journal-title":"N. Engl. J. Med."},{"key":"BFnrrheum201498_CR96","doi-asserted-by":"publisher","first-page":"2461","DOI":"10.1002\/art.21142","volume":"52","author":"K De Groot","year":"2005","unstructured":"De Groot, K. et al. Randomized trial of cyclophosphamide versus methotrexate for induction of remission in early systemic antineutrophil cytoplasmic antibody-associated vasculitis. Arthritis Rheum. 52, 2461\u20132469 (2005).","journal-title":"Arthritis Rheum."},{"key":"BFnrrheum201498_CR97","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1056\/NEJMoa0909905","volume":"363","author":"JH Stone","year":"2010","unstructured":"Stone, J. H. et al. Rituximab versus cyclophosphamide for ANCA-associated vasculitis. N. Engl. J. Med. 363, 221\u2013232 (2010).","journal-title":"N. Engl. J. Med."},{"key":"BFnrrheum201498_CR98","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1038\/nrd3838","volume":"12","author":"PC Fulkerson","year":"2013","unstructured":"Fulkerson, P. C. & Rothenberg, M. E. Targeting eosinophils in allergy, inflammation and beyond. Nat. Rev. Drug Discov. 12, 117\u2013129 (2013).","journal-title":"Nat. Rev. Drug Discov."},{"key":"BFnrrheum201498_CR99","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1097\/00005792-199601000-00003","volume":"75","author":"L Guillevin","year":"1996","unstructured":"Guillevin, L. et al. Prognostic factors in polyarteritis nodosa and Churg\u2013Strauss syndrome. A prospective study in 342 patients. Medicine (Baltimore) 75, 17\u201328 (1996).","journal-title":"Medicine (Baltimore)"},{"key":"BFnrrheum201498_CR100","doi-asserted-by":"publisher","first-page":"256","DOI":"10.5415\/apallergy.2012.2.4.256","volume":"2","author":"Y Kikkawa","year":"2012","unstructured":"Kikkawa, Y. et al. Interferon-\u03b1 inhibits airway eosinophilia and hyperresponsiveness in an animal asthma model [corrected]. Asia Pac. Allergy 2, 256\u2013263 (2012).","journal-title":"Asia Pac. Allergy"},{"key":"BFnrrheum201498_CR101","first-page":"24","volume":"28","author":"C Metzler","year":"2010","unstructured":"Metzler, C., Csernok, E., Gross, W. L. & Hellmich, B. Interferon-\u03b1 for maintenance of remission in Churg\u2013Strauss syndrome: a long-term observational study. Clin. Exp. Rheumatol. 28, 24\u201330 (2010).","journal-title":"Clin. Exp. Rheumatol."},{"key":"BFnrrheum201498_CR102","doi-asserted-by":"publisher","first-page":"R133","DOI":"10.1186\/ar4313","volume":"15","author":"J Thiel","year":"2013","unstructured":"Thiel, J., Hassler, F., Salzer, U., Voll, R. E. & Venhoff, N. Rituximab in the treatment of refractory or relapsing eosinophilic granulomatosis with polyangiitis (Churg\u2013Strauss syndrome). Arthritis Res. Ther. 15, R133 (2013).","journal-title":"Arthritis Res. Ther."},{"key":"BFnrrheum201498_CR103","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1016\/S1081-1206(10)61714-0","volume":"92","author":"N Tsurikisawa","year":"2004","unstructured":"Tsurikisawa, N. et al. Treatment of Churg\u2013Strauss syndrome with high-dose intravenous immunoglobulin. Ann. Allergy Asthma Immunol. 92, 80\u201387 (2004).","journal-title":"Ann. Allergy Asthma Immunol."},{"key":"BFnrrheum201498_CR104","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1023\/A:1025590308147","volume":"8","author":"A Druilhe","year":"2003","unstructured":"Druilhe, A., Letuve, S. & Pretolani, M. Glucocorticoid-induced apoptosis in human eosinophils: mechanisms of action. Apoptosis 8, 481\u2013495 (2003).","journal-title":"Apoptosis"},{"key":"BFnrrheum201498_CR105","first-page":"305","volume":"13","author":"J Corren","year":"2012","unstructured":"Corren, J. Inhibition of interleukin-5 for the treatment of eosinophilic diseases. Discov. Med. 13, 305\u2013312 (2012).","journal-title":"Discov. Med."},{"key":"BFnrrheum201498_CR106","doi-asserted-by":"publisher","first-page":"1336","DOI":"10.1016\/j.jaci.2010.03.028","volume":"125","author":"S Kim","year":"2010","unstructured":"Kim, S., Marigowda, G., Oren, E., Israel, E. & Wechsler, M. E. Mepolizumab as a steroid-sparing treatment option in patients with Churg\u2013Strauss syndrome. J. Allergy Clin. Immunol. 125, 1336\u20131343 (2010).","journal-title":"J. Allergy Clin. Immunol."},{"issue":"Suppl. 70","key":"BFnrrheum201498_CR107","first-page":"S62","volume":"30","author":"K Herrmann","year":"2012","unstructured":"Herrmann, K., Gross, W. L. & Moosig, F. Extended follow-up after stopping mepolizumab in relapsing\/refractory Churg\u2013Strauss syndrome. Clin. Exp. Rheumatol. 30 (Suppl. 70), S62\u2013S65 (2012).","journal-title":"Clin. Exp. Rheumatol."},{"key":"BFnrrheum201498_CR108","unstructured":"US National Library of Medicine. ClinicalTrials.gov [online] , (2014)."},{"key":"BFnrrheum201498_CR109","doi-asserted-by":"publisher","first-page":"332","DOI":"10.1046\/j.1365-2249.2001.125002332.x","volume":"125","author":"CE Balding","year":"2001","unstructured":"Balding, C. E., Howie, A. J., Drake-Lee, A. B. & Savage, C. O. TH2 dominance in nasal mucosa in patients with Wegener's granulomatosis. Clin. Exp. Immunol. 125, 332\u2013339 (2001).","journal-title":"Clin. Exp. Immunol."},{"key":"BFnrrheum201498_CR110","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1080\/09273940591004250","volume":"13","author":"P Choopong","year":"2005","unstructured":"Choopong, P. et al. Eosinophil activation in Wegener's granulomatosis: a harbinger of disease progression? Ocul. Immunol. Inflamm. 13, 439\u2013445 (2005).","journal-title":"Ocul. Immunol. Inflamm."},{"key":"BFnrrheum201498_CR111","doi-asserted-by":"publisher","first-page":"742","DOI":"10.1002\/1529-0131(199904)42:4<742::AID-ANR18>3.0.CO;2-I","volume":"42","author":"E Csernok","year":"1999","unstructured":"Csernok, E. et al. Cytokine profiles in Wegener's granulomatosis: predominance of type 1 (TH1) in the granulomatous inflammation. Arthritis Rheum. 42, 742\u2013750 (1999).","journal-title":"Arthritis Rheum."},{"key":"BFnrrheum201498_CR112","doi-asserted-by":"publisher","first-page":"1290","DOI":"10.1378\/chest.104.4.1290","volume":"104","author":"M Krupsky","year":"1993","unstructured":"Krupsky, M., Landau, Z., Lifschitz-Mercer, B. & Resnitzky, P. Wegener's granulomatosis with peripheral eosinophilia. Atypical variant of a classic disease. Chest 104, 1290\u20131292 (1993).","journal-title":"Chest"},{"key":"BFnrrheum201498_CR113","doi-asserted-by":"publisher","first-page":"1480","DOI":"10.1378\/chest.116.5.1480","volume":"116","author":"MB Potter","year":"1999","unstructured":"Potter, M. B., Fincher, R. K. & Finger, D. R. Eosinophilia in Wegener's granulomatosis. Chest 116, 1480\u20131483 (1999).","journal-title":"Chest"},{"key":"BFnrrheum201498_CR114","doi-asserted-by":"publisher","first-page":"1887","DOI":"10.1002\/1529-0131(200108)44:8<1887::AID-ART327>3.0.CO;2-8","volume":"44","author":"WH Schmitt","year":"2001","unstructured":"Schmitt, W. H., Linder, R., Reinhold-Keller, E. & Gross, W. L. Improved differentiation between Churg\u2013Strauss syndrome and Wegener's granulomatosis by an artificial neural network. Arthritis Rheum. 44, 1887\u20131896 (2001).","journal-title":"Arthritis Rheum."},{"key":"BFnrrheum201498_CR115","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1164\/ajrccm.161.2.9904076","volume":"161","author":"A Schnabel","year":"2000","unstructured":"Schnabel, A., Csernok, E., Braun, J. & Gross, W. L. Activation of neutrophils, eosinophils, and lymphocytes in the lower respiratory tract in Wegener's granulomatosis. Am. J. Respir. Crit. Care Med. 161, 399\u2013405 (2000).","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"BFnrrheum201498_CR116","first-page":"178","volume":"16","author":"T Kawasaki","year":"1967","unstructured":"Kawasaki, T. Acute febrile mucocutaneous syndrome with lymphoid involvement with specific desquamation of the fingers and toes in children [Japanese]. Arerugi 16, 178\u2013222 (1967).","journal-title":"Arerugi"},{"key":"BFnrrheum201498_CR117","doi-asserted-by":"publisher","first-page":"777","DOI":"10.1097\/00006454-200208000-00015","volume":"21","author":"M Terai","year":"2002","unstructured":"Terai, M. et al. Peripheral blood eosinophilia and eosinophil accumulation in coronary microvessels in acute Kawasaki disease. Pediatr. Infect. Dis. J. 21, 777\u2013781 (2002).","journal-title":"Pediatr. Infect. Dis. J."},{"key":"BFnrrheum201498_CR118","first-page":"160","volume":"12","author":"T Oner","year":"2012","unstructured":"Oner, T. et al. An observational study on peripheral blood eosinophilia in incomplete Kawasaki disease. Anadolu Kardiyol. Derg. 12, 160\u2013164 (2012).","journal-title":"Anadolu Kardiyol. Derg."},{"key":"BFnrrheum201498_CR119","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1001\/archderm.142.2.155","volume":"142","author":"S Bahrami","year":"2006","unstructured":"Bahrami, S., Malone, J. C., Webb, K. G. & Callen, J. P. Tissue eosinophilia as an indicator of drug-induced cutaneous small-vessel vasculitis. Arch. Dermatol. 142, 155\u2013161 (2006).","journal-title":"Arch. Dermatol."},{"key":"BFnrrheum201498_CR120","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1002\/jlb.52.6.611","volume":"52","author":"RI Abu-Ghazaleh","year":"1992","unstructured":"Abu-Ghazaleh, R. I. et al. Eosinophil granule proteins in peripheral blood granulocytes. J. Leukoc. Biol. 52, 611\u2013618 (1992).","journal-title":"J. Leukoc. Biol."},{"issue":"Suppl. 1","key":"BFnrrheum201498_CR121","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1111\/j.1365-2249.2011.04362.x","volume":"164","author":"CO Savage","year":"2011","unstructured":"Savage, C. O. Pathogenesis of anti-neutrophil cytoplasmic autoantibody (ANCA)-associated vasculitis. Clin. Exp. Immunol. 164 (Suppl. 1), 23\u201326 (2011).","journal-title":"Clin. Exp. Immunol."}],"container-title":["Nature Reviews Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/nrrheum.2014.98.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/nrrheum.2014.98","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/nrrheum.2014.98.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,29]],"date-time":"2024-05-29T04:52:32Z","timestamp":1716958352000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/nrrheum.2014.98"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,7,8]]},"references-count":121,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2014,8]]}},"alternative-id":["BFnrrheum201498"],"URL":"https:\/\/doi.org\/10.1038\/nrrheum.2014.98","relation":{},"ISSN":["1759-4790","1759-4804"],"issn-type":[{"value":"1759-4790","type":"print"},{"value":"1759-4804","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,7,8]]},"assertion":[{"value":"8 July 2014","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing financial interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}